- Home
- SIF vs MTVA Comparison
SIF vs MTVA Comparison
Compare SIF & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- MTVA
- Stock Information
- Founded
- SIF 1913
- MTVA 2014
- Country
- SIF United States
- MTVA United States
- Employees
- SIF N/A
- MTVA N/A
- Industry
- SIF Office Equipment/Supplies/Services
- MTVA
- Sector
- SIF Industrials
- MTVA
- Exchange
- SIF Nasdaq
- MTVA NYSE
- Market Cap
- SIF 18.6M
- MTVA 15.1M
- IPO Year
- SIF N/A
- MTVA N/A
- Fundamental
- Price
- SIF $3.88
- MTVA $0.67
- Analyst Decision
- SIF
- MTVA Strong Buy
- Analyst Count
- SIF 0
- MTVA 2
- Target Price
- SIF N/A
- MTVA $7.50
- AVG Volume (30 Days)
- SIF 21.3K
- MTVA 618.7K
- Earning Date
- SIF 05-15-2025
- MTVA 05-14-2025
- Dividend Yield
- SIF N/A
- MTVA N/A
- EPS Growth
- SIF N/A
- MTVA N/A
- EPS
- SIF N/A
- MTVA N/A
- Revenue
- SIF $83,554,000.00
- MTVA N/A
- Revenue This Year
- SIF N/A
- MTVA N/A
- Revenue Next Year
- SIF N/A
- MTVA N/A
- P/E Ratio
- SIF N/A
- MTVA N/A
- Revenue Growth
- SIF 35.83
- MTVA N/A
- 52 Week Low
- SIF $2.33
- MTVA $0.63
- 52 Week High
- SIF $5.96
- MTVA $5.30
- Technical
- Relative Strength Index (RSI)
- SIF 76.69
- MTVA N/A
- Support Level
- SIF $2.95
- MTVA N/A
- Resistance Level
- SIF $3.07
- MTVA N/A
- Average True Range (ATR)
- SIF 0.20
- MTVA 0.00
- MACD
- SIF 0.06
- MTVA 0.00
- Stochastic Oscillator
- SIF 98.22
- MTVA 0.00
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.